C. Charpin et al., REDUCED E-CADHERIN IMMUNOHISTOCHEMICAL EXPRESSION IN NODE-NEGATIVE BREAST CARCINOMAS CORRELATES WITH 10-YEAR SURVIVAL, AJCP. American journal of clinical pathology, 109(4), 1998, pp. 431-438
E-cadherin immunodetection was performed on frozen sections, using an
immunoperoxidase procedure and with computer-assisted analysis of digi
tized colored microscopic images in a series of 179 breast carcinomas.
Quantitative immunocytochemical assays were correlated with follow-up
(129 months). The results showed that reduced E-cadherin immunocytoch
emical expression in tumors (cut point, 4%) significantly correlated w
ith shorter overall survival in node-negative patients (Kaplan Meier l
og rank test). But E-cadherin immunostained expression (cut point, 4%)
did not correlate with metastasis-free or recurrence-free survival. I
n multivariate analysis (Cox proportional hazards regression model), E
-cadherin prognostic significance for overall survival in node-negativ
e patients was independent of the tumor size, grade, and histologic ty
pe. The results suggest that reduced E-cadherin expression detected in
optimum technical conditions (frozen samples and quantitative immunoh
istochemistry) is an independent indicator of poor survival in node-ne
gative patients and may be clinically relevant for the treatment of pa
tients with breast carcinomas.